Receiving a non-compliance letter from the NYSE is a significant negative regulatory event that typically leads to a decrease in investor confidence and can put downward pressure on the stock price in the short term. The issues of market capitalization and stockholders' equity are fundamental to a company's financial health, and failure to meet the required standards may lead to further regulatory action, including potential delisting.